{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:47:27Z","timestamp":1767134847054,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd005173.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":34,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005173.pub3","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T15:59:54Z","timestamp":1323100794000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tiagabine in the maintenance treatment of bipolar disorder"],"prefix":"10.1002","volume":"2012","author":[{"given":"Akshya","family":"Vasudev","sequence":"first","affiliation":[{"name":"London Health Sciences Centre, Victoria Hospital; University of Western Ontario; 800 Commissioners Road East PO BOX 5010 London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Macritchie","sequence":"additional","affiliation":[{"name":"University of Edinburgh; Division of Psychiatry; Royal Edinburgh Hospital Edinburgh UK EH10 5HF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay NK","family":"Rao","sequence":"additional","affiliation":[{"name":"Royal Victoria Infirmary; Newcastle-upon-Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford\/Warneford Hospital; Department of Psychiatry; Oxford UK OX3 7JX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[{"name":"Imperial College London; Division of Brain Sciences, Centre for Mental Health; London UK W6 8RP"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005173.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10401239809147036","article-title":"Adjunctive tiagabine treatment of psychiatric disorders: three cases","volume":"10","author":"Kauffman","year":"1998","journal-title":"Annals of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD005173.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1176\/ajp.156.12.2014-a","article-title":"Tiagabine and the treatment of refractory bipolar disorder","volume":"156","author":"Schaffer","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-0327(01)00407-4","article-title":"An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients","volume":"71","author":"Schaffer","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/sim.2423","article-title":"Meta-analysis of heterogeneously reported trials assessing change from baseline","volume":"24","author":"Abrams","year":"2005","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0165-0327(00)00203-2","article-title":"Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders","volume":"59 Suppl 1","author":"Akiskal","year":"2000","journal-title":"Journal of Affective Disorders"},{"issue":"7066","key":"10.1002\/14651858.CD005173.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0007|cit7","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD005173.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5-6","key":"10.1002\/14651858.CD005173.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuropharm.2009.07.027","article-title":"GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders","volume":"57","author":"Charych","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005173.pub3-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004367.pub2","article-title":"Olanzapine in long-term treatment for bipolar disorder","author":"Cipriani","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005173.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0012|cit12","first-page":"Epub","article-title":"Deficits in GABA(B) receptor system in schizophrenia and mood disorders: A postmortem study","volume":"Feb 7","author":"Fatemi","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD005173.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1528-1157.2001.042suppl.3042.x","article-title":"Tiagabine in clinical practice","volume":"42 Suppl 3","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD005173.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"A scaled version of the General Health Questionnaire","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder","volume":"164","author":"Goodwin","year":"1994","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005173.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0018|cit18","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0019|cit19","article-title":"Assessment of Study Quality.","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 ]; Section 6","author":"Higgins","year":"updated May 2005"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0020|cit20","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.0.0","author":"Higgins","year":"updated February 2008"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0021|cit21","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch16","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD005173.pub3-BIB0022|cit22","first-page":"S10","article-title":"Tiagabine: the safety landscape","volume":"36","author":"Leppik","year":"1995","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD005173.pub3-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004052","article-title":"Valproate for acute mood episodes in bipolar disorder","author":"Macritchie","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0024|cit24","unstructured":"Oxman A Preparing and maintaining systematic reviews Cochrane Collaboration Handbook Oxford John Wiley & Sons"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0025|cit25","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"5","key":"10.1002\/14651858.CD005173.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.1997.00550170069016","article-title":"Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group","volume":"54","author":"Sachdeo","year":"1997","journal-title":"Archives of Neurology."},{"key":"10.1002\/14651858.CD005173.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-5618.2002.01201.x","article-title":"Tiagabine in treatment refractory bipolar disorder: a clinical case series","volume":"4","author":"Suppes","year":"2002","journal-title":"Bipolar Disorders"},{"issue":"6","key":"10.1002\/14651858.CD005173.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD005173.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47- week study","volume":"160","author":"Tohen","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"Issue 3. Art. N","key":"10.1002\/14651858.CD005173.pub3-BIB0031|cit31","article-title":"Tiagabine in the treatment of acute affective episodes in bipolar disorder","author":"Vasudev","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005173.pub3-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004694.pub2","article-title":"Topiramate for acute affective episodes in bipolar disorder","author":"Vasudev","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005173.pub3-BIB0033|cit33","volume-title":"The World Health Organization. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"issue":"3","key":"10.1002\/14651858.CD005173.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005173.pub2","article-title":"Tiagabine in the maintenance treatment of bipolar disorders","author":"Vasudev","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005173.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:03:02Z","timestamp":1747296182000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005173.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005173.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}